Advertisement
Australia markets closed
  • ALL ORDS

    7,405.60
    +20.90 (+0.28%)
     
  • ASX 200

    7,194.90
    +21.60 (+0.30%)
     
  • AUD/USD

    0.6603
    +0.0001 (+0.01%)
     
  • OIL

    70.71
    +1.37 (+1.98%)
     
  • GOLD

    2,044.00
    -2.40 (-0.12%)
     
  • Bitcoin AUD

    66,256.59
    +449.01 (+0.68%)
     
  • CMC Crypto 200

    903.58
    +10.87 (+1.22%)
     
  • AUD/EUR

    0.6122
    +0.0012 (+0.20%)
     
  • AUD/NZD

    1.0737
    +0.0045 (+0.42%)
     
  • NZX 50

    11,495.64
    -0.97 (-0.01%)
     
  • NASDAQ

    16,022.49
    +234.44 (+1.48%)
     
  • FTSE

    7,526.61
    +12.89 (+0.17%)
     
  • Dow Jones

    36,117.38
    +62.95 (+0.17%)
     
  • DAX

    16,679.42
    +50.43 (+0.30%)
     
  • Hang Seng

    16,334.37
    -11.52 (-0.07%)
     
  • NIKKEI 225

    32,307.86
    -550.45 (-1.68%)
     

Better Dividend Stock: AbbVie or Viatris?

Better Dividend Stock: AbbVie or Viatris?

AbbVie (NYSE: ABBV) and Viatris (NASDAQ: VTRS) have a lot more in common than first glances would suggest. The two were both spun off from larger companies and now deliver above-average dividend yields. In AbbVie's case, it is the patent cliff next year for its immunology drug Humira, the top-selling drug last year other than COVID-19 vaccines.